FDA Of India State Cites Wockhardt For GMP Violations At Three Plants
This article was originally published in PharmAsia News
Executive Summary
India's Maharashtra FDA ordered Wockhardt to explain its lack of compliance with good manufacturing practices at three of its plants in the state, citing rusting barrels of raw material and insect infestation.